These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37111726)

  • 1. CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects.
    Yang Z; Li H; Zhang W; Zhang M; He J; Yu Z; Sun X; Ni P
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran-doxorubicin prodrug nanoparticles conjugated with CD147 monoclonal antibody for targeted drug delivery in hepatoma therapy.
    Tian H; Yu L; Zhang M; He J; Sun X; Ni P
    Colloids Surf B Biointerfaces; 2023 Aug; 228():113400. PubMed ID: 37331192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zwitterionic shielded polymeric prodrug with folate-targeting and pH responsiveness for drug delivery.
    Li L; Song Y; He J; Zhang M; Liu J; Ni P
    J Mater Chem B; 2019 Feb; 7(5):786-795. PubMed ID: 32254853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD326 monoclonal antibody modified core cross-linked curcumin-polyphosphoester prodrug for targeted delivery and cancer treatment.
    Li H; Zhang M; He J; Liu J; Sun X; Ni P
    J Mater Chem B; 2023 Oct; 11(39):9467-9477. PubMed ID: 37782068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of targeted killing of tumor-associated macrophages under photothermal conditions.
    Wang B; Huang Y
    Lasers Med Sci; 2022 Feb; 37(1):299-307. PubMed ID: 33439377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
    Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
    ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.
    Qiu Q; Li C; Song Y; Shi T; Luo X; Zhang H; Hu L; Yan X; Zheng H; Liu M; Liu M; Liu M; Yang S; Liu X; Chen G; Deng Y
    Acta Biomater; 2019 Jul; 92():184-195. PubMed ID: 31108259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
    Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
    Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-Doxorubicin Prodrug with Biocompatibility, pH Response, and Main Chain Breakability Prepared by Catalyst-Free Click Reaction.
    Li D; Song Y; He J; Zhang M; Ni P
    ACS Biomater Sci Eng; 2019 May; 5(5):2307-2315. PubMed ID: 33405781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and
    Hu R; Zheng H; Cao J; Davoudi Z; Wang Q
    J Biomed Nanotechnol; 2017 Dec; 13(9):1097-1105. PubMed ID: 31251142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts.
    Fend L; Accart N; Kintz J; Cochin S; Reymann C; Le Pogam F; Marchand JB; Menguy T; Slos P; Rooke R; Fournel S; Bonnefoy JY; Préville X; Haegel H
    PLoS One; 2013; 8(9):e73310. PubMed ID: 24019914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel targeted iron oxide nanocarrier for inhibiting M2-type macrophages in the tumor microenvironment.
    Tian K; Feng R; Wang X; Wu X; Li L; Liu W; Wu R
    J Cancer Res Ther; 2022 Sep; 18(5):1409-1416. PubMed ID: 36204890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Layer peeling" co-delivery system for enhanced RNA interference-based tumor associated macrophages-specific chemoimmunotherapy.
    Wang T; Mu W; Li F; Zhang J; Hou T; Pang X; Yin X; Zhang N
    Nanoscale; 2020 Aug; 12(32):16851-16863. PubMed ID: 32761008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
    Huang X; Liao W; Xie Z; Chen D; Zhang CY
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Functional Analysis of EPOR
    Li Y; Li M; Wei R; Wu J
    J Immunol Res; 2020; 2020():9374240. PubMed ID: 32908942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
    Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
    Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
    Tian H; Huang Y; He J; Zhang M; Ni P
    ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.